You are here

Since 2013, IDF Walk for Primary Immunodeficiency has raised more than $3 million. Because of the dollars raised by IDF walk teams and their supporters, IDF has established the IDF Research Grant Program, awarding grants to medical and scientific researchers to help improve the diagnosis, treatment, and quality of life of people living with PI.


The intent of the grant program is to support well-defined research projects that have a specified benefit for improving the treatment, health, disease management, or diagnosis of people with primary immunodeficiencies (PI). Consideration will also be given to studies that contribute to the body of medical knowledge in PI. See the "Previous Awardees" section for examples of projects that have been funded in the past.

Awards consist of one-year grants from $25,000 - $50,000 (a somewhat higher level of support is available for a few exceptional proposals).


The program is open to medical and scientific researchers currently based in the U.S.*

*These grants are not open to individuals employed by federal government agencies or departments.

Deadline and Application Process

The application submission deadline is February 28, 2023. Awardees will be announced in April 2023. If you have any questions or concerns with the application process, contact

Evaluation of Applications

Each research proposal is reviewed by IDF’s Research Committee, which is composed of immunologists who have a history of success obtaining and completing research grants. The Committee may also include prior IDF grant awardees.

The grant review process is based on the peer review system utilized by the National Institutes of Health (NIH). Scoring of grants is done individually by each member of the Research Committee and scores are added together to determine the final ranking of each proposal. The Committee recommends funding for the highest-scored proposals. Any reviewer with a conflict of interest is excused from voting on a specific proposal. The grant selection process is unbiased and independent; awards are based solely on scientific merit.

2023 Application

Fill out the information below, and a link to the grant application will be emailed to you. If you have any questions or technical difficulties, contact

Previous Awardees

Ranging from research on common variable immunodeficiency (CVID), severe combined immunodeficiency (SCID), XMEN, and selective IgA deficiency, IDF-supported researchers are identifying and understanding the underlying issues of these chronic diseases. With research comes better diagnoses, a better quality of life, and potential treatments for those with PI.





IDF Research Grant Program provided with support from Kedrion Biopharma.